• Product nameAnti-TPP1 antibody
    See all TPP1 primary antibodies
  • Description
    Goat polyclonal to TPP1
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Cow, Dog, Chimpanzee, Cynomolgus Monkey
  • Immunogen

    Synthetic peptide:


    , corresponding to internal sequence amino acids 201-215 of Human TPP1 (NP_000382.3).

  • Positive control
    • Human placenta lysate


Associated products


Our Abpromise guarantee covers the use of ab91512 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesWB: Use at a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 65 kDa (predicted molecular weight: 61 kDa).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionLysosomal serine protease with tripeptidyl-peptidase I activity. May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases. Requires substrates with an unsubstituted N-terminus.
    • Tissue specificityDetected in all tissues examined with highest levels in heart and placenta and relatively similar levels in other tissues.
    • Involvement in diseaseDefects in TPP1 are the cause of neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500]. A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment pattern seen most often in CLN2 consists of curvilinear profiles.
    • Sequence similaritiesBelongs to the peptidase S53 family.
    • Post-translational
      Activated by autocatalytic proteolytical processing upon acidification. N-glycosylation is required for processing and activity.
    • Cellular localizationLysosome. Melanosome. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.
    • Information by UniProt
    • Database links
    • Alternative names
      • Cell growth inhibiting gene 1 protein antibody
      • Cell growth-inhibiting gene 1 protein antibody
      • Ceroid lipofuscinosis neuronal 2 antibody
      • Ceroid lipofuscinosis neuronal 2 late infantile (Jansky Bielschowsky disease) antibody
      • Ceroid lipofuscinosis neuronal 2 late infantile antibody
      • CLN 2 antibody
      • CLN2 antibody
      • GIG 1 antibody
      • GIG1 antibody
      • Growth inhibiting protein 1 antibody
      • LPIC antibody
      • Lysosomal pepstatin insensitive protease antibody
      • Lysosomal pepstatin-insensitive protease antibody
      • MGC21297 antibody
      • TPP 1 antibody
      • TPP I antibody
      • TPP-1 antibody
      • TPP-I antibody
      • Tpp1 antibody
      • TPP1_HUMAN antibody
      • TPPI antibody
      • Tripeptidyl aminopeptidase antibody
      • Tripeptidyl peptidase I antibody
      • Tripeptidyl-peptidase 1 antibody
      • Tripeptidyl-peptidase I antibody
      see all

    Anti-TPP1 antibody images

    • Anti-TPP1 antibody (ab91512) at 0.3 µg/ml + Human placenta lysate at 35 µg
      developed using the ECL technique

      Predicted band size : 61 kDa
      Observed band size : 65 kDa (why is the actual band size different from the predicted?)

      Exposure time : 1 hour

    References for Anti-TPP1 antibody (ab91512)

    ab91512 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab91512.
    Please use the links above to contact us or submit feedback about this product.